|
Grant Bagley, MD, JD, is currently a practicing attorney with Arnold Porter where he focuses on reimbursement, healthcare policy, and healthcare strategy issues. Prior to joining that firm, Dr. Bagley was a Director in the Coverage and Analysis Group at HCFA (now CMS). He spent 3 years working as a Medical Officer at the FDA and, prior to that, spent many years as a practicing gynecologist. David Feigal MD, MPH,is the former director of CDRH, the medical device center, of the FDA. He is now a principal at NDA Partners, a consulting firm specializing in regulatory issues. Before leaving clinical medicine, Dr. Feigal was a practicing internist at UCSF and was part of the team that developed aerosolized pentamadine. Frank Fischer is the CEO of Neuropace. Mr Fischer has more than 25 years of senior management experience in the medical device industry. He has served on the NeuroPace Board of Directors since 1998 and joined the Company as its Chief Executive Officer in January 2000. Prior to joining NeuroPace, Mr. Fischer was President and Chief Executive Officer of Heartport, Inc., a cardiac surgery company, from May 1998 until September 1999 and served on Heartport's Board of Directors. Mr. Fischer was President and Chief Executive Officer and a director of Ventritex, Inc., a company that pioneered implantable cardiac defibrillators, from 1987 until the sale of the company to St. Jude Medical, Inc. in early 1997. Before joining Ventritex, he spent 10 years in various management positions at Cordis Corporation in the cardiac and neurosurgical device areas, serving most recently as President of the Implantable Products Division. Prior to that, he spent 7 years with General Electric Company in a variety of operating positions. Mr. Fischer holds an M.S. in Management from Rensselaer Polytechnic Institute. Currently, he serves on the boards of 1 public and several privately held medical device companies. Ray Larkin was most recently Chairman and CEO of Eunoe Inc, a medical technology company focused on Alzheimer’s disease. During his career Mr. Larkin was Chairman and CEO of Nellcor Puritan Bennett, Inc., a medical instrumentation company that was acquired by Mallinckrodt, Inc. in 1997 for $2.1 billion. During Mr. Larkin's tenure as CEO of Nellcor, revenue grew from $120 million to approximately $1B. After Nellcor Mr Larkin served on several boards of directors and served as a Principal of Group Outcome, a merchant banking firm concentrating on medical technologies. Mr. Larkin also held various positions of increasing responsibility at Bentley Laboratories/American Hospital Supply from 1976 to 1983. Prior to that, he was a captain in the US Marine Corps and received his Bachelor of Sciences degree in industrial management from LaSalle University. Tom Slagle is currently group president of Distribution for the Medical Products and Services group of Cardinal Health. The Distribution business is the leading distributor and marketer of medical/surgical/laboratory products, and supply chain solutions serving U.S. hospitals, clinical laboratories, physicians’ offices, surgery centers in the United States. Mr. Slagle also held positions of increasing responsibility at Johnson & Johnson Ortho Diagnostics Division, Baxter Healthcare. Robert Thomas was the CEO of Fox Hollow Technologies. Mr. Thomas joined Fox Hollow in 1998 as VP of Operations and became CEO in 2000. While in the CEO position at Fox Hollow Mr Thomas guided the redesign of the company’s core product, successfully completed the regulatory process, and directed the launch of the product. This resulted in Fox Hollow being the fastest revenue ramping venture backed medical technology company in history as of the date of it's IPO. The company had a market capitalization of $1B at the time of Mr. Thomas' departure. Before joining FoxHollow, Mr. Thomas was Vice President of Operations at Conceptus where he was instrumental in the ramp-up of its manufacturing facilities. Prior to Conceptus, Mr. Thomas spent 7 years growing Thomas Medical, a company he founded and later sold to Vital Signs, Inc. Before founding Thomas Medical, Mr. Thomas held various management positions with Baxter Healthcare. Mr. Thomas holds a Bachelor of Arts degree in Economics from Ursinus College.
|
|
Clinical Advisors:
Rod Altman, MD, is a Senior Partner at CMEA Ventures. Rod worked closely with Ned at PJV until late 2004. Prior to PJV he was a partner at Techno Venture Management. Rod was the Assistant Medical Director of the emergency department at MacNeal Hospital in suburban Chicago and a Clinical Instructor at the University of Chicago. Rod continues to practice emergency medicine at Stanford University Medical Center where he is a Clinical Assistant Professor of Emergency Medicine in the Department of Surgery. Donald Baim, MD, FACC, is one of the nation’s leading interventional cardiologists. He practices at Brigham & Women’s Hospital, is the Director of its Center for Integration of Medicine and Innovative Technology, and is a Professor at Harvard Medical School. Dr. Baim was educated at Stanford, Harvard, Yale, and the University of Chicago. He is an author of over 300 publications. He has served on numerous scientific advisory boards and boards of directors. He has advised numerous start-up companies and large medical device companies. Reginald Davis, MD, FACS, is a neurosurgeon who spends 70% of his practice time focused on spinal surgery. Dr. Davis is the Head of Neurosurgery at Greater Baltimore Medical Center, an Assistant Professor at the Johns Hopkins School of Medicine, and a Clinical Assistant Professor at the University of Maryland. His medical school, neurosurgical residency, and spinal surgery fellowship all occurred at the Johns Hopkins School of Medicine. He has worked with Medtronic’s spine division, Zimmer, and numerous smaller spine companies. John Gutheil, MD,is a medical oncologist and currently Vice President of Medical Affairs at Favrille. Prior to that, Dr. Gutheil was Executive Director of Clinical Research and Development at Vical. Before moving to the business world, Dr. Gutheil was engaged in clinical research at the Sidney Kimmel Cancer Center and the University of Maryland. He received degrees from UC San Diego and the Medical College of Wisconsin, and oncology training at the University of Maryland. Thomas Krummel, MD, FACS,is a general surgeon and pediatric surgeon at Stanford University Medical Center. He is Chairman and Professor of Surgery at Stanford. Dr. Krummel trained at Children’s Hospital of Pittsburgh, Medical College of Virginia, Medical College of Wisconsin, and the University of Wisconsin. He is an author of over 100 peer-reviewed journal articles. Dr. Krummel is the founder of the Surgical Innovation Program @ Stanford, a fellowship program in which surgeons and engineers will design new surgical products, and he is a director of Stanford Biodesign, a biomedical engineering collaboration. William J. Maloney, III, MD, FAAOS, is Chairman and Professor of Orthopedic Surgery at Stanford. Formerly Chief of Orthopaedic Surgery at Barnes-Jewish Hospital and Professor or Orthopaedic Surgery at Washington University School of Medicine in St Louis. His fellowship training was in hip and reconstructive surgery at Massachusetts General Hospital (Harvard). Other training took place at Stanford and Columbia. Dr. Maloney is an author of over 100 publications. Dr. Maloney is the designer of numerous products and has worked closely with Zimmer Orthopedics and Wright Medical, Inc. David Paushter MD, FAIUM, is Vice Chairman and Professor of Radiology at the University of Chicago effective November 2005. Dr. Paushter is also a Consulting Physician with The Tiber Group where he focuses on practice management and reimbursement issues. Before joining the University of Chicago, Dr. Paushter practiced at MacNeal Hospital and the Cleveland Clinic. His fellowship was in abdominal imaging at Georgetown University. His also trained at Cleveland Clinic, Case Western Reserve University, and University of Rochester. He has authored over 75 publications.
|
|
